Blocking <scp>STAT3</scp> /5 through direct or upstream kinase targeting in leukemic cutaneous T‐cell lymphoma-Reference-Cited by-同舟云学术

Blocking STAT3 /5 through direct or upstream kinase targeting in leukemic cutaneous T‐cell lymphoma

Published:2022-11-07 Issue:12 Volume:14 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Sorger Helena¹²^ORCID,Dey Saptaswa³⁴^ORCID,Vieyra‐Garcia Pablo Augusto³^ORCID,Pölöske Daniel¹,Teufelberger Andrea R³^ORCID,de Araujo Elvin D⁵⁶^ORCID,Sedighi Abootaleb⁵⁶,Graf Ricarda⁷,Spiegl Benjamin⁷^ORCID,Lazzeri Isaac⁷,Braun Till⁸,Garces de los Fayos Alonso Ines⁴⁹,Schlederer Michaela⁴,Timelthaler Gerald¹⁰,Kodajova Petra⁹^ORCID,Pirker Christine¹⁰¹¹,Surbek Marta¹,Machtinger Michael¹,Graier Thomas³,Perchthaler Isabella³,Pan Yi³^ORCID,Fink‐Puches Regina³,Cerroni Lorenzo³,Ober Jennifer¹²,Otte Moritz⁸,Albrecht Jana D¹³,Tin Gary⁵⁶,Abdeldayem Ayah⁵⁶,Manaswiyoungkul Pimyupa⁵⁶,Olaoye Olasunkanmi O⁵⁶,Metzelder Martin L²,Orlova Anna¹^ORCID,Berger Walter¹⁰¹¹,Wobser Marion¹⁴,Nicolay Jan P¹³,André Fiona¹⁵,Nguyen Van Anh¹⁵^ORCID,Neubauer Heidi A¹^ORCID,Fleck Roman¹⁶,Merkel Olaf⁴,Herling Marco⁸¹⁷,Heitzer Ellen⁷,Gunning Patrick T⁵⁶¹⁶^ORCID,Kenner Lukas⁴⁹¹¹¹⁸¹⁹^ORCID,Moriggl Richard¹^ORCID,Wolf Peter³²⁰^ORCID

Affiliation:

1. Unit of Functional Cancer Genomics, Institute of Animal Breeding and Genetics University of Veterinary Medicine Vienna Austria

2. Department of Pediatric and Adolescent Surgery, Vienna General Hospital Medical University of Vienna Vienna Austria

3. Department of Dermatology and Venereology Medical University of Graz Graz Austria

4. Department of Pathology Medical University of Vienna Vienna Austria

5. Department of Chemical and Physical Sciences University of Toronto Mississauga Mississauga ON Canada

6. Centre for Medicinal Chemistry University of Toronto Mississauga Mississauga ON Canada

7. Diagnostic & Research Center for Molecular Bio‐Medicine, Institute of Human Genetics Medical University of Graz Graz Austria

8. Department of Medicine I CIO‐ABCD, CECAD and CMMC Cologne University Cologne Germany

9. Unit of Laboratory Animal Pathology University of Veterinary Medicine Vienna Vienna Austria

10. Centre for Cancer Research Medical University of Vienna Vienna Austria

11. Comprehensive Cancer Center Medical University of Vienna Vienna Austria

12. Core Facility Flow Cytometry, Center for Medical Research (ZMF) Medical University of Graz Graz Austria

13. Department of Dermatology University Hospital Mannheim Mannheim Germany

14. Department of Dermatology University Hospital Wuerzburg Wuerzburg Germany

15. University Clinic for Dermatology, Venereology and Allergology Innsbruck Medical University of Innsbruck Innsbruck Austria

16. Janpix, a Centessa Company London UK

17. Department of Hematology, Cellular Therapy, and Hemostaseology University of Leipzig Leipzig Germany

18. Christian Doppler Laboratory for Applied Metabolomics (CDL‐AM), Division of Nuclear Medicine Medical University of Vienna Vienna Austria

19. CBmed GmbH Center for Biomarker Research in Medicine Graz Austria

20. BioTechMed Graz Graz Austria

Funder

Austrian Science Fund

Medizinische Universität Graz

European Association for Cancer Research

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202115200

Reference61 articles.

1. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors

2. Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal

3. An overview of cutaneous T cell lymphomas

4. QuPath: Open source software for digital pathology image analysis

5. Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitorsHNRNPKandSOCS1in mycosis fungoides

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule STAT3/5 inhibitors exhibit therapeutic potential in acute myeloid leukemia and extra-nodal natural killer/T cell lymphoma;2023-10-18

2. Small molecule STAT3/5 inhibitors exhibit therapeutic potential in acute myeloid leukemia and extra-nodal natural killer/T cell lymphoma;2023-10-16

3. A lineage-specificSTAT5B^N642Hmouse model to study NK-cell leukemia;2023-10-06

4. Specific Targeting of STAT3 in B Cells Suppresses Progression of B Cell Lymphoma;International Journal of Molecular Sciences;2023-09-04

5. The rise of degrader drugs;Cell Chemical Biology;2023-08